Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
基本信息
- 批准号:10207370
- 负责人:
- 金额:$ 47.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-05 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAlcohol abuseAlcohol consumptionAlcohol-Induced DisordersAlcoholic HepatitisAlcoholic Liver DiseasesAnti-Inflammatory AgentsAntiviral AgentsAntiviral ResponseApoptosisApoptoticBAX geneBax proteinCellsCessation of lifeChronicCirrhosisComplexDNADataDevelopmentDouble-Stranded RNAElementsEthanolExhibitsFailureFibrosisGenesGenetic TranscriptionHepaticHepatitisHomeostasisIRF3 geneImmuneImmune responseInflammationInflammatoryInnate Immune ResponseInnate Immune SystemInterferonsKnock-in MouseLigandsLiverLysineMediatingMitochondriaMolecularMorbidity - disease rateMusNatural ImmunityPathogenesisPathologyPathway interactionsPatientsPeripheralPhenotypePopulationProteinsRegulationReporterResearch PersonnelResolutionRoleSignal PathwaySignal TransductionStimulator of Interferon GenesTLR4 geneTherapeutic InterventionTissuesUbiquitinationViral PhysiologyVirus Diseasesalcohol exposurealcohol responsecellular targetingchronic inflammatory diseaseds-DNAexperimental studyhepatocellular injuryimprovedinjury and repairliver injurymacrophagemembermicrobialmigrationmonocytemortalitymouse modelnovelpreventpro-apoptotic proteinreceptorrecruitresponsetherapeutic targettranscription factor
项目摘要
ABSTRACT
Alcohol consumption is a leading cause of preventable morbidity and mortality worldwide. Chronic alcohol abuse
underlies the pathogenesis of alcoholic liver disease (ALD), encompassed by a spectrum of pathologies, ranging
from steatosis, to more severe forms of liver injury, including alcoholic hepatitis (AH), fibrosis, and cirrhosis.
There is a growing appreciation of a dynamic and complex role of the innate immune system in the progression
of ALD, as well as the resolution of hepatocellular injury and fibrosis. The controlled and appropriate resolution
of inflammation is an essential feature of the innate immune response. This dynamic interplay between injury
and repair is mediated, at least in part, by the tremendous plasticity of resident tissue macrophages and
infiltrating monocytes as they respond to signals within their microenvironment.
Signaling via IRF3 is an important element in the dynamic regulation of pro-survival vs pro-death pathways in
immune cells. While several studies have implicated IRF3 in the progression of ALD, the mechanisms by which
IRF3 contributes to liver injury are not well understood. Classically, IRF3 is known as a transcription factor
essential for the induction of interferon- (IFN-) and antiviral genes. Recently, members of our team discovered
that, in addition to its transcriptional functions, IRF3 directly triggers a pro-apoptotic pathway, termed RIG-I-
like receptors (RLR)-induced IRF-3-mediated pathway of apoptosis (RIPA) via a non-transcriptional
mechanism. In IRF3-mediated apoptosis, IRF3 is activated by linear ubiquitination on two lysine residues,
resulting in the interaction of IRF3 with the pro-apoptotic protein Bax. The IRF3/BAX complex then translocates
to the mitochondria where it triggers apoptosis. In order to study this pathway, we have generated a novel
knock-in mouse that expresses an IRF3 protein that only exhibits non-transcriptional functions.
Importantly, in preliminary experiments, we discovered that IRF3-mediated apoptosis of innate immune cells
recruited to the liver in response to Gao-binge ethanol exposure dynamically exacerbates inflammation and
contributes to murine alcoholic hepatitis (mAH). Here we propose to investigate the mechanisms by which the
non-transcriptional activity of IRF3 contributes to both hepatic inflammation and fibrosis in models of mAH and
fibrosis in 2 specific aims: SA1) Determine the contribution of the non-transcriptional function of IRF3 in mediating
ethanol-induced liver injury in the Gao-binge model of mAH and a murine model of acceleration of fibrosis by
ethanol and SA2) Investigate the mechanisms of IRF3 activation in immune cells during mAH or fibrosis. In
summary, our studies will reveal novel roles for the non-transcriptional activity of IRF3 in exacerbating innate
immune responses to alcohol, as well as identify potential therapeutic targets that would prevent and/or improve
the resolution of inflammation and fibrosis in patients with ALD.
抽象的
饮酒是全球可预防的发病率和死亡率的主要原因。慢性酒精滥用
基于酒精性肝病(ALD)的发病机理,包括一系列病理学
从脂肪变性到更严重的肝损伤形式,包括酒精性肝炎(AH),纤维化和肝硬化。
对先天免疫系统在进展中的动态和复杂作用越来越欣赏
ALD,以及肝细胞损伤和纤维化的分辨率。受控且适当的分辨率
炎症是先天免疫反应的重要特征。受伤之间的这种动态相互作用
至少部分是由居民组织巨噬细胞的巨大可塑性和
当它们对微环境中的信号响应时,渗透单核细胞。
通过IRF3信号传导是促生存期与亲死亡途径的动态调节中的重要元素
虽然几项研究已经在ALD的发展中实施了IRF3,但该机制的机制
IRF3导致肝损伤的原因尚不清楚。从经典上讲,IRF3被称为转录因子
诱导干扰素-(IFN-)和抗病毒基因必不可少的。最近,我们团队的成员发现
除了其转录函数外,IRF3还直接触发了促凋亡途径,称为rig-ii
像受体(RLR)诱导的IRF-3介导的凋亡途径(RIPA)通过非转录
机制。在IRF3介导的凋亡中,IRF3通过在两个赖氨酸残基上的线性泛素化激活,
导致IRF3与促凋亡蛋白Bax的相互作用。然后易位的IRF3/BAX复合物
到线粒体触发凋亡的线粒体。为了研究这一途径,我们产生了一个新颖
表达仅表现出非转录功能的IRF3蛋白的敲入小鼠。
重要的是,在初步实验中,我们发现IRF3介导的先天免疫细胞凋亡
响应Gao-Binge乙醇暴露的招募到肝脏会动态加剧注射和
有助于鼠类酒精性肝炎(MAH)。在这里,我们建议研究
IRF3的非转录活性在MAH和MAH模型中有助于肝注射和纤维化
2个特定目的的纤维化:SA1)确定IRF3非转录功能的贡献
乙醇诱导的MAH的GAO-BEING模型和纤维化加速度的鼠模型在乙醇中诱导的肝损伤
乙醇和SA2)研究MAH或纤维化期间免疫细胞中IRF3激活的机制。在
总而言之,我们的研究将揭示IRF3非转录活性在加剧先天性中的新作用
对酒精的免疫反应,并确定可以预防和/或改进的潜在治疗靶标
ALD患者的炎症和纤维化的分辨率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURA E. NAGY其他文献
LAURA E. NAGY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURA E. NAGY', 18)}}的其他基金
Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
- 批准号:
10173028 - 财政年份:2019
- 资助金额:
$ 47.99万 - 项目类别:
Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
- 批准号:
10430300 - 财政年份:2019
- 资助金额:
$ 47.99万 - 项目类别:
Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
- 批准号:
9765602 - 财政年份:2019
- 资助金额:
$ 47.99万 - 项目类别:
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair
AH 中的微生物代谢物和先天免疫:损伤和修复的生物标志物
- 批准号:
10428502 - 财政年份:2018
- 资助金额:
$ 47.99万 - 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
- 批准号:
10227144 - 财政年份:2018
- 资助金额:
$ 47.99万 - 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
- 批准号:
9753072 - 财政年份:2018
- 资助金额:
$ 47.99万 - 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
- 批准号:
10457954 - 财政年份:2018
- 资助金额:
$ 47.99万 - 项目类别:
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair
AH 中的微生物代谢物和先天免疫:损伤和修复的生物标志物
- 批准号:
9791131 - 财政年份:2018
- 资助金额:
$ 47.99万 - 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
- 批准号:
9977058 - 财政年份:2018
- 资助金额:
$ 47.99万 - 项目类别:
相似国自然基金
年龄与异质对酗酒影响的建模与分析
- 批准号:11861044
- 批准年份:2018
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
酗酒相关问题的建模及研究
- 批准号:11461041
- 批准年份:2014
- 资助金额:36.0 万元
- 项目类别:地区科学基金项目
酗酒者易患肺部感染及高致死率的发病机制研究
- 批准号:U1404814
- 批准年份:2014
- 资助金额:30.0 万元
- 项目类别:联合基金项目
与酗酒毒害性相关的细胞色素CYP2E1蛋白酶催化反应机理及动力学的理论研究
- 批准号:21273095
- 批准年份:2012
- 资助金额:78.0 万元
- 项目类别:面上项目
酗酒促发外伤性蛛网膜下腔出血的生物力学机制及其量化法医病理学鉴定的研究
- 批准号:30772458
- 批准年份:2007
- 资助金额:28.0 万元
- 项目类别:面上项目
相似海外基金
Neurodevelopment of exploration and alcohol problems in adolescence
青春期探索和酒精问题的神经发育
- 批准号:
10628964 - 财政年份:2023
- 资助金额:
$ 47.99万 - 项目类别:
Substance Use and Firearm Injuries among Medicaid-enrolled Youth
参加医疗补助的青少年的药物使用和枪伤
- 批准号:
10811094 - 财政年份:2023
- 资助金额:
$ 47.99万 - 项目类别:
Advancing Couple and Family Alcohol Treatment through Patient-Oriented Research and Mentorship
通过以患者为导向的研究和指导推进夫妻和家庭酒精治疗
- 批准号:
10644311 - 财政年份:2023
- 资助金额:
$ 47.99万 - 项目类别:
Adapting mHealth interventions to improve self-management of HIV and substance use among emerging adults in Zambia
采用移动医疗干预措施,改善赞比亚新兴成年人对艾滋病毒和药物滥用的自我管理
- 批准号:
10813460 - 财政年份:2023
- 资助金额:
$ 47.99万 - 项目类别:
INROADS-A: Intersecting Research on Addiction and Disability Services - Alcohol
INROADS-A:成瘾和残疾服务的交叉研究 - 酒精
- 批准号:
10777298 - 财政年份:2023
- 资助金额:
$ 47.99万 - 项目类别: